Table 4.
The univariate and multivariable HRs (95% CI) for quartiles of 25(OH)D.
2-year follow-up | 7-year follow-up | |||
---|---|---|---|---|
Univariate analysis | Multivariable analysis* | Univariate analysis | Multivariable analysis* | |
Total population | ||||
Total mortality | 0.61 (0.37–1.00) P = 0.05 |
0.79 (0.45–1.40) P = 0.40 |
0.66 (0.48–0.89) P = 0.008 |
0.79 (0.57–1.09) P = 0.15 |
Cardiac death | 0.70 (0.37–1.34) P = 0.29 |
0.83 (0.40–1.72) P = 0.61 |
NA | NA |
SCD | 0.59 (0.14–2.44) P = 0.46 |
1.28 (0.26–6.37) P = 0.76 |
NA | NA |
| ||||
TnT pos. population | ||||
Total mortality | 0.59 (0.33–1.04) P = 0.07 |
0.82 (0.42–1.61) P = 0.56 |
0.60 (0.41–0.87) P = 0.008 |
0.74 (0.49–1.12) P = 0.15 |
Cardiac death | 0.71 (0.36–1.41) P = 0.33 |
1.09 (0.49–2.42) P = 0.84 |
NA | NA |
SCD | 0.58 (0.14–2.44) P = 0.46 |
1.52 (0.30–7.72) P = 0.61 |
NA | NA |
| ||||
Females | ||||
Total mortality | 0.43 (0.19–0.94) P = 0.035 |
0.65 (0.26–1.62) P = 0.36 |
0.51 (0.32–0.83) P = 0.006 |
0.64 (0.38–1.10) P = 0.09 |
Cardiac death | 0.35 (0.13–0.98) P = 0.046 |
0.61 (0.19–2.00) P = 0.41 |
NA | NA |
SCD | 0.0 (0.00-0.00) P = 0.96 |
NA | NA | NA |
| ||||
Males | ||||
Total mortality | 0.85 (0.46–1.57) P = 0.61 |
0.81 (0.40–1.65) P = 0.56 |
0.82 (0.56–1.24) P = 0.36 |
0.73 (0.47–1.12) P = 0.15 |
Cardiac death | 1.09 (0.46–2.56) P = 0.85 |
0.89 (0.32–2.46) P = 0.83 |
NA | NA |
SCD | 0.99 (0.20–4.88) P = 0.99 |
1.92 (0.31–12.1) P = 0.49 |
NA | NA |
SCD, sudden cardiac death.
*Adjusted for gender, age, smoking, hypertension, index diagnosis, diabetes mellitus, CHF (defined by Killip-Kimball class at admission; patients in classes 2 to 4 were classified as CHF patients and those in class 1 as non-CHF), history of previous CHD (i.e., history of either angina pectoris, myocardial infarction, percutaneous coronary intervention, or coronary artery bypass graft), hypercholesterolemia/use of statins, TnT >0.01 ng/mL, eGFR, hsCRP, BNP, body mass index (kg/m2), and beta-blockers prior to enrolment.